Biotech

Latest Articles

Cassava spends $40M over supposedly misleading Alzheimer's upgrade

.Cassava Sciences has consented to spend $40 thousand to settle an investigation in to cases it made...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has picked up choices on 2 Evaxion Biotech vaccination applicants, paying $3.2 thous...

Enanta's RSV antiviral crushes viral lots in obstacle research study

.Enanta Pharmaceuticals has linked its respiratory system syncytial virus (RSV) antiviral to signifi...

Biogen cans SAGE-324 partnership after important agitation neglect

.Biogen has carried out the last ceremonies to its partnership with Sage Therapeutics on SAGE-324, b...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's ailment drugs are being actually questioned, AbbVie has ...

Arch closes $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Financing Lifestyle Sciences, Arc Project Allies...

Orion to make use of Aitia's 'digital doubles' to locate brand new cancer medications

.Finnish biotech Orion has actually snooped possible in Aitia's "electronic double" technology to bu...

Windtree's surprise med brings up high blood pressure in most up-to-date period 2 succeed

.While Windtree Therapies has battled to expand the monetary origins needed to endure, a phase 2 win...

2 cancer biotechs merge, creating worldwide footprint

.OncoC4 is actually taking AcroImmune-- and its internal scientific manufacturing abilities-- under ...

Amgen reports 1st phase 3 win for $400M chronic eczema medication

.Amgen has actually shared (PDF) the first stage 3 information on its $400 thousand chronic eczema m...

Biogen, UCB document phase 3 lupus gain after neglecting earlier trial

.Biogen and UCB's gamble on developing in to period 3 astride a broken research study tries to have ...

Aptadir really hopes brand-new RNA preventions can easily turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has introduced with the guarantee that its pipe of preclinical...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) resea...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using ...

Achilles drips tissue treatment system, braces for cutbacks after missing out on 'office stability' targets

.Achilles Therapeutics has actually wrecked its own approach. The English biotech is knocking off on...

Aligos trumpets period 2 MASH win, reducing liver fat around 46%

.Aligos Therapeutics is actually declaring a midstage win in metabolic-dysfunction linked steatohepa...

Basilea credit ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand new antifungals has acquired a substantial improvement c...

Capricor markets Europe civil liberties to late-stage DMD treatment for $35M

.Possessing currently gathered up the U.S. civil liberties to Capricor Therapies' late-stage Duchenn...

FDA scraps adcomm for Applied's unusual ailment medication

.After pushing back the selection date for Applied Therapies' metabolic condition medicine govoresta...

Novo inks $600M NanoVation offer to research genetic drugs ex-liver

.Novo Nordisk is proceeding its own push right into genetic medicines, accepting to pay NanoVation T...